Domvanalimab is an investigational medication being studied for its potential to help the immune system fight cancer. It is being tested in combination with other treatments to see if it can improve survival in patients with certain types of advanced stomach and esophageal cancers.

Zimberelimab is another investigational medication that is part of the trial. It is designed to work with the immune system to target and destroy cancer cells. Researchers are studying its effectiveness when used alongside other therapies in treating advanced cancers of the stomach and esophagus.

Nivolumab is a medication that helps the immune system recognize and attack cancer cells. It is already used in the treatment of various cancers and is being tested in this trial to see how well it works in combination with chemotherapy for patients with advanced stomach and esophageal cancers.

Chemotherapy refers to the use of drugs to kill or slow the growth of cancer cells. In this trial, chemotherapy is used in combination with other medications to evaluate its effectiveness in treating advanced cancers of the stomach and esophagus.

Esophageal Cancer – This is a disease where malignant cells form in the tissues of the esophagus, the tube that carries food from the throat to the stomach. It often begins in the cells lining the inside of the esophagus and can grow to invade deeper layers and nearby structures. As it progresses, it may cause difficulty swallowing, weight loss, and chest pain. The cancer can spread to nearby lymph nodes and other parts of the body. Risk factors include smoking, heavy alcohol use, and certain dietary habits.

Gastric Cancer – Also known as stomach cancer, this disease involves the growth of cancerous cells within the lining of the stomach. It typically starts in the mucus-producing cells on the stomach’s inner surface and can develop into a tumor. As it advances, it may lead to symptoms like indigestion, stomach pain, nausea, and loss of appetite. The cancer can spread to nearby organs and lymph nodes. Factors such as infection with Helicobacter pylori, smoking, and certain dietary factors can increase the risk.

Metastatic Esophageal Cancer – This condition occurs when esophageal cancer spreads beyond the esophagus to other parts of the body, such as the liver, lungs, or bones. The spread of cancer cells can lead to additional symptoms depending on the organs affected. It often results in more severe symptoms and complications compared to localized esophageal cancer. The progression involves the cancer cells traveling through the bloodstream or lymphatic system. This stage of cancer is more challenging to manage due to its widespread nature.

Metastatic Gastric Cancer – This form of cancer arises when gastric cancer cells spread from the stomach to other areas of the body, such as the liver, lungs, or peritoneum. The spread can cause new symptoms related to the affected organs, in addition to those caused by the primary tumor. The cancer cells can travel through the blood or lymphatic system to distant sites. This stage indicates a more advanced progression of the disease, often leading to complex clinical scenarios.